Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,439.95
(
-0.82%
)
US TECH 100
28,458.00
(
-1.16%
)
Dow Jones
49,665.40
(
-0.80%
)
Brent Oil
106.52
(
2.24%
)
Bitcoin
79,014.02
(
-2.52%
)
News Focus
News Focus
Post# of 257568
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122984
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Dub Narcotic post# 105031

Friday, 09/24/2010 11:18:17 PM

Friday, September 24, 2010 11:18:17 PM

Post# of 257568

Cladribine doesn't win on efficacy, safety or convenience. I'm not sure where the market is. Second and third-line salvage therapy, I suppose.

Cladribine’s best shot is in the second-line needle-phobic setting :- )

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today